Belkin Laser Ltd., one of BioLight’s Portfolio companies, has completed its extended investment round (in which BioLight invested USD1M)

Tel Aviv (June 25, 2020) – BioLight is pleased to announce that  Belkin Laser Ltd., one of BioLight’s portfolio companies in which it invested on December 2019, USD 1M, has extended and completed its total investment round (which increased from a total of  USD10M  to USD 12M due to over demand of current and new investors).

[1] Holding via XL Vision Sciences Ltd. (wholly owned subsidiary) approx. 89% of the issued and share capital of Diagnostear (approx. 86% fully diluted).

Link to the complete article

Link to Newsroom

Comments are closed.